Skip to content
healthcare.dev
Get a free key

POMBILITI ATGA

NDC 71904-200, cipaglucosidase alfa-atga, injection, powder, lyophilized, for solution, from AMICUS THERAPEUTICS US, LLC.

Product NDC
71904-200
Status
Listed
Labeler
AMICUS THERAPEUTICS US, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761204
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71904-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CIPAGLUCOSIDASE ALFA105 mg/1

Pharmacologic classes

Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]; alpha-Glucosidases [CS]

Package NDCNDC-11Package
71904-200-01719040200011 VIAL, GLASS in 1 CARTON (71904-200-01) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
71904-200-027190402000210 VIAL, GLASS in 1 CARTON (71904-200-02) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
71904-200-037190402000325 VIAL, GLASS in 1 CARTON (71904-200-03) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d77aa596-910d-516b-e053-2995a90a0839

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71904-200

Use it

Look up 71904-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71904-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71904-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.